Current Issue

February 2023

Cardiovascular Complications of Chronic Rheumatic Diseases
George A. Karpouzas, MD, M. Elaine Husni, MD, MPH, Editor

Disease-specific or -associated immune responses further contribute to atherosclerosis development by affecting lipoprotein composition and function, cholesterol loading to arterial wall macrophages, foam cell formation, plaque instability, and rupture. Several of them serve as predictive and prognostic biomarkers, optimizing risk estimates for atherosclerotic plaque presence, progression, and cardiovascular events above and beyond traditional risk factor models. The evaluation of subclinical atherosclerosis across various vascular territories and using different, noninvasive imaging modalities, additionally optimize cardiovascular risk estimates. Future risk prediction models combining traditional risk factors, disease-specific characteristics, information from disease-associated biomarkers, imaging, and synthesized with the help of machine- and deep-learning modalities of artificial intelligence may further optimize risk recognition and allow the development of more effective and comprehensive cardioprotective strategies.

Articles in Press

Most Read


The Clinics Journals

Loading ...

Discover everything the Clinics journals have to offer.

About the Journal

Rheumatic Disease Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue (February, May, August, and November) focuses on a single topic in rheumatology and is presented under the direction of an experienced editor. Topics include osteoarthritis, rheumatoid arthritis, crystal diseases, MSK exam, disorders of the bone, immunodeficiency states, lupus, neuromuscular disease, pain disorders, scleroderma, vasculitis, pediatrics, therapeutics, treatment guidelines, and treatment modalities.